Rep. Richard Neal (D-Mass.) received $54,000 from lobbyists for private equity and pharmaceutical interests that opposed a bipartisan surprise medical billing deal in the weeks after he stymied the deal with a last-minute counterproposal.
In contrast with Sanders and other Democrats, Biden has not embraced a key executive authority for driving down the cost of pharmaceuticals developed with federally-funded research, like the coronavirus vaccine that is currently being tested.
As she votes on regulations impacting the pharmaceutical industry, Massachusetts Public Health Commissioner Monica Bharel's spouse works as a consultant for companies that seek to influence the department's regulatory rulemakings.
Rep. Richard Neal (D-Mass.) torpedoed a fix tp surprise medical billing that threatened his private equity donors' profits. The coronavirus outbreak makes this potentially deadly.
From Big Tobacco to opioid crisis profiteering, Paul, Weiss, Rifkind, Wharton & Garrison LLP has made millions from defending some of the most repugnant corporate villains of recent decades
In touting the endorsement of Josh Black, the Buttigieg campaign declined to mention that Black now works for the pharmaceutical industry’s top lobbying group.
More than a dozen high-powered lawyers and executives, including the man who inspired Gordon Gekko, will help “Middle-Class Joe” raise campaign cash in early January.
Kristen Hawn, a communications consultant, appears on emails with industry-backed groups strategizing against health care changes.
The staffers, several of whom work for reps on the subcommittee overseeing pharmaceuticals, met with executives from drug companies Merck and Genentech.
After Rep. Greg Walden, the biggest recipient of pharmaceutical campaign cash in the last election cycle, met with Trump, the president decided to scrap his support for lower drug prices.